Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
eNq1mE1z2jAQhu/8Co8PveHPEExrk2lp0jKTTCkJ004vjLDXQdRIriQTp7++ApOGdMSECnTEst9d764evTi+qJeFtQLGMSWJ7TuebQFJaYbJfWJP7q7akX3Rb8ULtEI7t3Udz/ED20oLxHlir1edGSDCne831x9BPg/M7resmM4WkIoX91UCF85nxOc3qFzfY8UrijNrCWJOs8QuK7G5asVcMJlF/4Gyn7xEKcTu9sru6mJ6tns9dtdiB6hWHNg1IvdKUSBammnFGBAxQALuKXtUSufpNIi6554XaYXAfAycViyFERLzEaMrnEGmjoQKDlpB8ofsFtiqALEOohR3F+mSa4mjBarH8GuoTvq9XB2IWrS9tt/tdIOe3wt64VmoFYrtlEo9PPIl3HTqh2HgRaELxE3neMZojQm0CWV5QWuUyh+avRpRJlBhqEuYD17Om6E4DH69Og0Z5mWBHp0FL3VLhRiSy8AkFcy9yPoN7pjkVCFr9o8+qYrC/c+sJ1uKGMp4DakBrYjYA5OrsW4hBpQIqPd3VI9/ot7OIgZ+OtnflKjZP6pmBU51ESchVAEXk/FwP+FMwuED4jBh5ujwDZOMPvDTU2e3y4ayLzfgVIqWLPOnQS869zsd7U31Q47UnhPosmK0BFfyCPNjMDMkOT0WMHJK1VJPM2psPDf2iKaogD0Gqa3JHjmXT37O2OSb21XNglL00+Wd7rh8rYA93m5+KqVxlvxttB6YTdBeDudriTfbOCmnodeJpI17g5bluyfnnWi67Eb0AJN9FoWB3vAzNXrmQpT8revOEW9zJEvq5OzwY+JCWY1TVEQy+bnB5v4TGPEMjYdqeGwo9Vlz0B7eUt19/JqjONYlb5/funFlDMEqOKIPDfKNgXl4eXrWP1tkY2mPXhDHXJiNnUUCU2LKVlUzpeJxp4vsK7liEg5f8hzv+Uyzdy5jt/lE1G/F7vrzUL/1B4X1Gg8=
1y6WSXK1WX4XbNAN
Listen
